MILAN, Feb 11 (Reuters) – Moderna shares opened 14% lower in Frankfurt on Wednesday in low volume after the U.S. Food and Drug Administration refused to review the company’s approval application for its influenza vaccine. The company’s shares, which closed up 0.1% on Tuesday, are up 42% so far this year. (Reporting by Danilo Masoni; […]
Health
Moderna shares fall after FDA refuses to review new flu vaccine
Audio By Carbonatix
MILAN, Feb 11 (Reuters) – Moderna shares opened 14% lower in Frankfurt on Wednesday in low volume after the U.S. Food and Drug Administration refused to review the company’s approval application for its influenza vaccine.
The company’s shares, which closed up 0.1% on Tuesday, are up 42% so far this year.
(Reporting by Danilo Masoni; Editing by Amanda Cooper)